WO2018231704A8 - 6-bromonicotinamide and processes of preparation - Google Patents
6-bromonicotinamide and processes of preparation Download PDFInfo
- Publication number
- WO2018231704A8 WO2018231704A8 PCT/US2018/036896 US2018036896W WO2018231704A8 WO 2018231704 A8 WO2018231704 A8 WO 2018231704A8 US 2018036896 W US2018036896 W US 2018036896W WO 2018231704 A8 WO2018231704 A8 WO 2018231704A8
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- bromonicotinamide
- processes
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C07D213/82—Amides; Imides in position 3
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/34—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom
- A01N43/40—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom six-membered rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Agronomy & Crop Science (AREA)
- Pest Control & Pesticides (AREA)
- Plant Pathology (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Dentistry (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Pyridine Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Provided herein are processes for the preparation 6-bromonicotinamide.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201762518091P | 2017-06-12 | 2017-06-12 | |
US62/518,091 | 2017-06-12 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2018231704A1 WO2018231704A1 (en) | 2018-12-20 |
WO2018231704A8 true WO2018231704A8 (en) | 2019-01-17 |
Family
ID=64659434
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2018/036896 WO2018231704A1 (en) | 2017-06-12 | 2018-06-11 | 6-bromonicotinamide and processes of preparation |
Country Status (2)
Country | Link |
---|---|
AR (1) | AR112095A1 (en) |
WO (1) | WO2018231704A1 (en) |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1516938A (en) * | 1976-05-01 | 1978-07-05 | Pfizer Ltd | Halopyridylamides of m-aminotetramisole and their use as anthelmintics |
EP0281965A1 (en) * | 1987-03-09 | 1988-09-14 | Ici Americas Inc. | Method of converting a carboxylic acid or carboxylic acid halide group to a trihalomethyl group |
US6022884A (en) * | 1997-11-07 | 2000-02-08 | Amgen Inc. | Substituted pyridine compounds and methods of use |
US6777432B1 (en) * | 2001-09-04 | 2004-08-17 | Darwin Molecular Corporation | Pharmaceutical uses and synthesis of nicotinamides |
US20040067985A1 (en) * | 2002-10-04 | 2004-04-08 | Fortuna Haviv | Method of inhibiting angiogenesis |
-
2018
- 2018-06-11 WO PCT/US2018/036896 patent/WO2018231704A1/en active Application Filing
- 2018-06-12 AR ARP180101603A patent/AR112095A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2018231704A1 (en) | 2018-12-20 |
AR112095A1 (en) | 2019-09-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA202107931B (en) | Anti-tau antibodies and methods of use | |
MX2021006237A (en) | Anti-tigit antibodies, anti-pvrig antibodies and combinations thereof. | |
WO2018109170A3 (en) | Il-11ra antibodies | |
WO2017124002A8 (en) | Multispecific immunomodulatory antigen-binding constructs | |
WO2018109174A3 (en) | Il-11 antibodies | |
WO2018081648A8 (en) | Anti-mic antibodies and methods of use | |
AU2018258581A8 (en) | RAF-degrading conjugate compounds | |
MY191581A (en) | Anti-pd-1 antibodies | |
WO2018106776A3 (en) | Anti-tau antibodies and methods of their use | |
EP3800248A3 (en) | Crispr-cas-related methods, compositions and components for cancer immunotherapy | |
EP4112611A3 (en) | Modulators of sestrin-gator2 interaction and uses thereof | |
WO2015179658A3 (en) | Anti-gpc3 antibodies and immunoconjugates | |
EP3893883A4 (en) | Methods for the treatment of depression | |
PH12018502233A1 (en) | ErbB INHIBITORS AND USES THEREOF | |
EP3717808A4 (en) | Seal, assembly, and methods of using the same | |
EP3596824B8 (en) | An amplifier | |
EP3622205A4 (en) | Seal, assembly, and methods of using the same | |
MX2019000246A (en) | Solid state forms of palbociclib dimesylate. | |
EP3551619A4 (en) | Compositions comprising methylphenidate-prodrugs, processes of making and using the same | |
EP3599770A4 (en) | Headphones | |
EP4285930A3 (en) | Protein formulations | |
SG10201908248PA (en) | Processes for preparing fluoroketolides | |
MX2023006458A (en) | Immunomodulatory oligosaccharides. | |
AU201715153S (en) | Ramp | |
MX2016016233A (en) | Anti-lgr5 antibodies and uses thereof. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 18817713 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 18817713 Country of ref document: EP Kind code of ref document: A1 |